Genetic association of α2-macroglobulin with Alzheimer's disease in a Finnish elderly population

Annals of Neurology

Volumn 46, Issue 3, 1999, Pages 382-390

  Myllykangas, Liisa ^a,b   Polvikoski, Tuomo ^b   Sulkava, Raimo ^c   Verkkoniemi, Auli ^b   Crook, Richard ^a   Tienari, Pentti J ^b   Pusa, Anna Kaisa ^b   Niinistö, Leena ^d   O'Brien, Peter ^e   Kontula, Kimmo ^b   Hardy, John ^a   Haltia, Matti ^b   Pérez Tur, Jordi ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

^d Katriina Geriatric Hospital   (Finland)

^e MAYO CLINIC ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN BIOPSY; CHROMOSOME 12; FEMALE; FINLAND; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; ADULT; AGE; GENETICS; GENOTYPE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

ALPHA 2 MACROGLOBULIN;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; CHROMOSOMES, HUMAN, PAIR 12; FEMALE; FINLAND; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 0032587839     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199909)46:3<382::AID-ANA14>3.0.CO;2-5     Document Type: Article

References (38)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981
2. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-9653
3. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-1247
4. Bales KR, Verina T, Dodel RC, et al. Lack of apolipoprotein E dramatically reduces amyloid-beta peptide deposition. Nat Genet 1997;17:263-264
5. Pericak-Vance MA, Bass MP, Yamaoka LH, et al. Complete genomic screen in late-onset familial Alzheimer disease: evidence for a locus on chromosome 12. JAMA 1997;278:1237-1241
6. Wu WS, Holmans P, Wavrant-DeVrieze F, et al. Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA 1998;280:619-622
7. Rogaeva E, Premkumar S, Song Y, et al. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. JAMA 1998;280:614-618
8. van Gool D, de Strooper B, van Leuven F, et al. a2-Macroglobulin expression in neuritic-type plaques in patients with Alzheimer's disease. Neurobiol Aging 1993;14:233-237
9. Rebeck GW, Harr SD, Strickland DK, Hyman BT. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the a2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Neurology 1995; 37:211-217
10. Lendon CL, Talbot CJ, Craddock NJ, et al. Genetic association studies between dementia of the Alzheimers type and three receptors for apolipoprotein E in a caucasian population. Neurosci Lett 1997;222:187-190
11. Wavrant-DeVrieze F, Perez-Tur J, Lambert JC, et al. Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett 1997;227: 68-70
12. Clatworthy AE, Gomez-Isla T, Rebeck GW, et al. Lack of association of a polymorphism in the low-density lipoprotein receptor-related protein gene with Alzheimer disease. Arch Neurol 1997;54:1289-1292
13. Fallin D, Kundtz A, Town T, et al. No association between the low density lipoprotein receptor-related protein (LRP) gene and late-onset Alzheimer's disease in a community-based sample. Neurosci Lett 1997;233:145-147
14. Blacker D, Wilcox MA, Laird NM, et al. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat Genet 1998;19:357-360
15. Liao A, Nitsch RM, Greenberg SM, et al. Genetic association of an alpha2-macroglobulin (Val1000Ile) polymorphism and Alzheimer's disease. Hum Mol Genet 1998;7:1953-1956 (In press)
16. Wavrant-De Vrieze F, Rudrasingham V, Lambert J-C, et al. No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci Lett 1999;262: 137-139
17. Rudrasingham V, Wavrant-De Vrieze F, Lambert J-C, et al. Alpha-2 macroglobulin and Alzheimer disease: association or linkage? Nat Genet 1999;22:17-19 (Letter)
18. Kowal RC, Herz J, Goldstein JL, et al. Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. Proc Natl Acad Sci USA 1989;86:5810-5814
19. Du Y, Glinn M, Dodel RC, et al. α2-Macroglobulin as a amyloid peptide-binding plasma protein. J Neurochem 1997;69: 299-305
20. Hughes SR, Khorkova O, Goyal S, et al. a2-Macroglobulin associates with β-amyloid peptide and prevents fibril formation. Proc Natl Acad Sci USA 1998;95:3275-3280
21. Qiu WQ, Borth W, Ye Z, et al. Degradation of amyloid β-protein by a serine protease-α2-macroglobulin complex. J Biol Chem 1996;271:8443-8451
22. Du Y, Bales KR, Dodel RC, et al. α2-Macroglobulin attenuates β-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J Neurochem 1998;70:1182-1188
23. Strauss S, Bauer J, Ganter U, et al. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 1992;66: 223-230
24. Northemann W, Andus T, Gross V, Heinrich PC. Cell-free synthesis of rat alpha 2-macroglobulin and induction of its mRNA during experimental inflammation. Eur J Biochem 1983;137:257-262
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed, revised. Washington, DC: American Psychiatric Association, 1987
26. Mirra SS, Heyman A, McKeel D. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486
27. Yamaguchi H, Haga C, Hirai S, et al. Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain. Acta Neuropathol 1990;79:569-572
28. Yamamoto T, Hirano A. A comparative study of modified Bielschowsky, Bodian and thioflavin S stain on Alzheimer's neurofibrillary tangles. Neuropathol Appl Neurobiol 1986;12: 3-9
29. Allsop D, Haga S-I, Haga C, et al. Early senile plaques in Down's syndrome brains show close relationship with cell bodies of neurons. Neuropathol Appl Neurobiol 1989;15:531-542
30. Gundersen HJ, Bendtsen TF, Korbo L, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Apmis 1988;96:379-394
31. Matthijs G, Marynen P. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene. Nucleic Acids Res 1991;19:5102
32. Poller W, Faber J-P, Klobeck G, Olek K. Cloning of the human a2-macroglobulin gene and detection of mutations in two functional domains: the bait region and the thiolester site. Hum Genet 1992;88:313-319
33. Siffert W, Rosskopf D, Siffert G, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998;18:45-48 (Comment)
34. Nothen MM, Dewald G. A common amino acid polymorphism in complement component C1R. Hum Mol Genet 1994;3:217
35. Xie X, Ott J. Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 1993;535:1107
36. Narita M, Holtzman DM, Schwartz AL, Bu G. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J Neurochem 1997;69:1904-1911
37. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 1996;2:864-870
38. Rebeck WA, Reiter JS, Strickland DK, Hyman BT. Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993;11:575-580